Financial results for Q3 ended September 30, 2025
GlaxoSmithKline (Pakistan) Limited (GLAXO) · View GLAXO share price and financials
Published
Announcement summary
This page records a Pakistan Stock Exchange corporate announcement from GlaxoSmithKline (Pakistan) Limited. Review the original filing for the complete terms and regulatory disclosure.
- Unconsolidated Sales
- 14188008
- Unconsolidated Pat
- 2037285
- Bonus
- 0
- Unconsolidated Quarter Eps
- 6.40
- Ex Date
- 2025-09-30
- Right Price
- 0
- Unconsolidated Cumulative Eps
- 19.57